Distinct inhibition of acute cocaine-stimulated motor activity following microinjection of a group III metabotropic glutamate receptor agonist into the dorsal striatum of rats

Group III metabotropic glutamate receptors (mGluRs) are negatively coupled to adenylate cyclase through G-proteins. Activation of this group of mGluRs shows an inhibition of dopaminergic transmission in the forebrain. To defi ne the role of striatal group III mGluRs in the regulation of basal and dop amine-stimulated motor behavior, the recently developed agonist and antagon ist relatively selective for group III mGluRs were utilized to pharmacologi cally enhance and reduce group III mGluR glutamatergic tone in the dorsal s triatum of chronically cannulated rats. Bilateral injections of a group III agonist, L-2-amino-4 -phosphonobutyrate (L-AP4), did not alter basal level s of motor activity at three doses surveyed (1, 10, and 100 nmol). Neither did intracaudate injection of a group m antagonist, alpha -methyl-4-phospho nophenylglycine (MPPG), at 10, 30, and 100 nmol. However, pretreatment with L-AP4 (10 and 100 nmol) dose dependently blocked hyperlocomotion induced b y acute injection of cocaine (20 mg/kg, i.p.), amphetamine (2.5 mg/kg, i.p. ), or apomorphine (1 mg/kg, s.c.). The behavioral activity induced by cocai ne was much more sensitive to L-AP4 than that induced by amphetamine and ap omorphine. At 100 nmol, L-AP4 completely blocked cocaine effect whereas amp hetamine- and apomorphine-stimulated behaviors were blocked only by 28% and 31%, respectively. The blocking effect of L-AP4 on cocaine action was reve rsed by pretreatment with MPPG. MPPG itself did not modify behavioral respo nses to cocaine, amphetamine, or apomorphine. These data indicate that the glutamatergic tone on the group III mGluRs is not active in the regulation of basal and acute dopamine-stimulated motor activity. However, enhanced gr oup III mGluR glutamatergic transmission by an exogenous ligand is capable of suppressing behavioral responses to acute exposure of dopamine stimulant s. (C) 2000 Elsevier Science Inc. All rights reserved.